Computational network pharmacology and molecular simulations to explore the potential mechanisms of Pyrrosia piloselloides compounds against prostate cancer.
4 affiliations
- 1Medical Study Program, Faculty of Medicine, Universitas Palangka Raya, University of Palangka Raya, Palangkaraya, 73111, Indonesia.
- 2Department of Pharmacotherapy, Faculty of Medicine, Universitas Palangka Raya, University of Palangka Raya, Palangkaraya, 73111, Indonesia. [email protected].
- 3Department of Pharmacotherapy, Faculty of Medicine, Universitas Palangka Raya, University of Palangka Raya, Palangkaraya, 73111, Indonesia.
- 4Study Program of Chemistry, Faculty of Mathematics and Natural Sciences, University of Palangka Raya, Palangkaraya, Indonesia.
Abstract
Background
Prostate cancer is major cause of cancer-related morbidity and mortality in men worldwide. Emerging evidence highlights the dragon scale fern (Pyrrosia piloselloides or P. piloselloides) has demonstrated anticancer potential, but its molecular mechanisms against prostate cancer remain unclear. The study aimed to investigate its potential anticancer compounds and underlying molecular mechanisms using an integrated in silico approach.Methods
A structured computational workflow integrating network pharmacology, molecular simulations, and MM/GBSA analysis was employed to explore the potential mechanism of bioactive compounds of P. piloselloides against prostate cancer-related targets. Additionally, the pharmacokinetic and toxicity profiles were evaluated using ADMET prediction.Results
Eight bioactive compounds of the plants were identified as potentially interacting with 32 prostate cancer-related proteins, including nine key targets: ESR1, MYC, CTNNB1, PPARG, AKT1, STAT3, BCL2, AR, and ERBB2. Clustering analysis identified 20 proteins within the major cluster, that subsequently dianalisis enrichment idapati bahwa mereka were associated with 235 molecular functions, 142 cellular components, and more than 1,000 biological processes, including epithelial cell proliferation dan identified terlibat dalam 161 enriched pathways, including the PI3K-Akt and ERBB signaling pathways. Docking analysis revealed variable predicted binding affinities, particularly for 7-dehydrodiosgenin 3-acetate against ERBB2 (- 11.85 kcal/mol), AKT1 (- 9.49 kcal/mol), and BCL2 (- 9.38 kcal/mol), stigmasterol against PPARG (- 9.63 kcal/mol), ERBB2 (- 9.94 kcal/mol), and AR (- 9.31 kcal/mol), and 6-hydroxymethaqualone against ESR1 (- 9.34 kcal/mol). Molecular dynamics simulations indicated overall structural stability with localized flexibility, while MM/GBSA analysis yielded favorable predicted binding free energies for ERBB2 with 6-hydroxymethaqualone (- 45.57 kcal/mol), PPARG with stigmasterol (- 41.52 kcal/mol), and BCL2 with 7-dehydrodiosgenin 3-acetate (- 23.35 kcal/mol). The compounds also showed generally favorable predicted ADMET profiles, providing basis for further experimental evaluation.Conclusion
The integrated computational analysis identified 6-hydroxymethaqualone, stigmasterol, and 7-dehydrodiosgenin 3-acetate as compounds with promising predicted interactions across prostate cancer-related targets. These findings provide a basis for further investigation and experimental validation.
Related
- Molecular Targets and Potential Mechanisms of Luteolin Against Cervical Carcinoma: Integrative Approach Combining Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations, and In Vitro Validation.
- Unveiling Molecular Basis of Terminalia chebula in Modulating the AGE-RAGE-PRKCB Axis in Diabetic Nephropathy: Integrative Network Pharmacology and Computational Study
- Study on the Active Constituents and Underlying Mechanisms of Renshen Yangying Decoction Against Angina Pectoris Based on Integrated Serum Pharmacochemistry, Network Pharmacology, Molecular Docking, and Experimental Validation
- Unveiling the molecular mechanisms of clozapine-induced seizures: a network pharmacology and molecular docking-based investigation
- Flavonoids in cancer pharmacology: molecular mechanisms, tumor microenvironment regulation, and drug resistance
BibTeX
@article{havid2026computational,
title = {{Computational network pharmacology and molecular simulations to explore the potential mechanisms of Pyrrosia piloselloides compounds against prostate cancer.}},
author = {Husnul Havid and Ysrafil Ysrafil and Fatmaria Fatmaria and Muhammad Rifqi Musyaffa and Masira Sony Crespo Sinuhaji and Remi Ayu Pratika},
journal = {Journal of the Egyptian National Cancer Institute},
year = {2026},
month = oct,
doi = {10.1186/s43046-026-00421-3},
url = {https://europepmc.org/article/MED/42955205},
note = {CC BY},
}
RIS
TY - JOUR
TI - Computational network pharmacology and molecular simulations to explore the potential mechanisms of Pyrrosia piloselloides compounds against prostate cancer.
AU - Husnul Havid
AU - Ysrafil Ysrafil
AU - Fatmaria Fatmaria
AU - Muhammad Rifqi Musyaffa
AU - Masira Sony Crespo Sinuhaji
AU - Remi Ayu Pratika
PY - 2026
DA - 2026/10/29
JO - Journal of the Egyptian National Cancer Institute
DO - 10.1186/s43046-026-00421-3
UR - https://europepmc.org/article/MED/42955205
AB - Background Prostate cancer is major cause of cancer-related morbidity and mortality in men worldwide. Emerging evidence highlights the dragon scale fern (Pyrrosia piloselloides or P. piloselloides) has demonstrated anticancer potential, but its molecular mechanisms against prostate cancer remain unclear. The study aimed to investigate its potential anticancer compounds and underlying molecular mechanisms using an integrated in silico approach.Methods A structured computational workflow integrating network pharmacology, molecular simulations, and MM/GBSA analysis was employed to explore the potential mechanism of bioactive compounds of P. piloselloides against prostate cancer-related targets. Additionally, the pharmacokinetic and toxicity profiles were evaluated using ADMET prediction.Results Eight bioactive compounds of the plants were identified as potentially interacting with 32 prostate cancer-related proteins, including nine key targets: ESR1, MYC, CTNNB1, PPARG, AKT1, STAT3, BCL2, AR, and ERBB2. Clustering analysis identified 20 proteins within the major cluster, that subsequently dianalisis enrichment idapati bahwa mereka were associated with 235 molecular functions, 142 cellular components, and more than 1,000 biological processes, including epithelial cell proliferation dan identified terlibat dalam 161 enriched pathways, including the PI3K-Akt and ERBB signaling pathways. Docking analysis revealed variable predicted binding affinities, particularly for 7-dehydrodiosgenin 3-acetate against ERBB2 (- 11.85 kcal/mol), AKT1 (- 9.49 kcal/mol), and BCL2 (- 9.38 kcal/mol), stigmasterol against PPARG (- 9.63 kcal/mol), ERBB2 (- 9.94 kcal/mol), and AR (- 9.31 kcal/mol), and 6-hydroxymethaqualone against ESR1 (- 9.34 kcal/mol). Molecular dynamics simulations indicated overall structural stability with localized flexibility, while MM/GBSA analysis yielded favorable predicted binding free energies for ERBB2 with 6-hydroxymethaqualone (- 45.57 kcal/mol), PPARG with stigmasterol (- 41.52 kcal/mol), and BCL2 with 7-dehydrodiosgenin 3-acetate (- 23.35 kcal/mol). The compounds also showed generally favorable predicted ADMET profiles, providing basis for further experimental evaluation.Conclusion The integrated computational analysis identified 6-hydroxymethaqualone, stigmasterol, and 7-dehydrodiosgenin 3-acetate as compounds with promising predicted interactions across prostate cancer-related targets. These findings provide a basis for further investigation and experimental validation.
SN - 1110-0362
SN - 2589-0409
ER -